Reduction of the Glycemic Index by a Novel Viscous Polysaccharide

July 8, 2009 updated by: Glycemic Index Laboratories, Inc

Effect of Adding the Novel Fiber, PGX®,to Commonly Consumed Foods on Glycemic Response and Glycemic Index: A Practical and Effective Strategy for Reducing Post Prandial Blood Glucose Levels.

Reductions of postprandial glucose levels have been demonstrated previously with the addition of a novel viscous polysaccharide (NVP) to a glucose drink and standard white bread. This study explores whether these reductions are sustained when NVP is added to a range of commonly consumed foods.

Study Overview

Detailed Description

Recently, a commercial novel viscous polysaccharide (NVP)complex has been developed which is marketed in both the USA and Canada under the trade name PGX® (PolyGlycopleX) (InovoBiologic Inc, Calgary, AB, Canada). This complex consists of three viscous non starch polysaccharides which are processed using proprietary technology (EnviroSimplex®) to produce compressed granules which delays the onset of viscosity and increases palatability of the fiber when added to food. Previously, this fibre was shown to lower postprandial glucose levels in a dose responsive manner when mixed with a glucose drink and sprinkled onto a standard white bread demonstrating that the processing did not interfere with the effectiveness of the fiber. From this study the reduction in GI was calculated to be 7 units per gram of NVP when added to a solid food, however it is not known whether this relationship would be maintained when the NVP was added to a range of commonly eaten foods. This study therefore evaluates the effect of the addition or incorporation of NVP into a range of foods on postprandial glycemia and whether the reductions in glycemic index could be predicted using.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada
        • Glycemic Index Laboratories, Inc.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • healthy individuals
  • 18-75 years old
  • BMI less than 35 kg/m2

Exclusion Criteria:

  • Medications influencing gastrointestinal function
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: 1
Control White bread containing 50g available carbohydrate
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Placebo Comparator: 2
White bread and milk control
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Placebo Comparator: 3
Granola control
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Placebo Comparator: 4
Cornflakes and milk control
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Placebo Comparator: 5
White rice control
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Placebo Comparator: 6
Fruit yogurt control
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Placebo Comparator: 7
Turkey dinner control
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Experimental: 8
Granola
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Experimental: 9
Cornflakes and milk
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Experimental: 10
White Rice
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Experimental: 11
Fruit yogurt
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Experimental: 12
Turkey dinner
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Placebo Comparator: 13
White Bread
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Placebo Comparator: 14
White bread
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX
Experimental: 15
Granola
2.5 grams of PGX
5.0 grams of PGX
0 grams of PGX

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Relative Blood glucose response of food with and without NVP
Time Frame: Acute blood glucose response measured at 0, 15,30,45,60,90 and 120 min
Acute blood glucose response measured at 0, 15,30,45,60,90 and 120 min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2006

Primary Completion (Actual)

June 1, 2006

Study Completion (Actual)

August 1, 2006

Study Registration Dates

First Submitted

March 25, 2009

First Submitted That Met QC Criteria

July 8, 2009

First Posted (Estimate)

July 9, 2009

Study Record Updates

Last Update Posted (Estimate)

July 9, 2009

Last Update Submitted That Met QC Criteria

July 8, 2009

Last Verified

July 1, 2009

More Information

Terms related to this study

Other Study ID Numbers

  • GIL-6033

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Glucose, Postprandial

Clinical Trials on PolyGlycopleX (PGX)

3
Subscribe